Non-Invasive Prenatal Testing Market worth USD 3.01 billion by 2021
The growth of the Global Non-Invasive Prenatal Testing Market is in particular driven by way of elements inclusive of the advent of newer and more advanced NIPT merchandise, the feasibility and developing choice
(EMAILWIRE.COM, April 06, 2018 ) The Global Non-Invasive Prenatal Testing Market turned into well worth USD 1.46 billion in 2016 and is projected to be growing at a CAGR of 15.6%, to the touch USD 3.01 billion by using 2021. Non-Invasive Prenatal Testing (NIPT) is a brand new sort of genetic test that monitors for inherited illnesses and start defects. It typically entails a simple blood screening that analyses the DNA, known as mobile-loose DNA(cf-DNA) to exactly estimate a child’s risk for a ramification of genetic problems, including Down syndrome.
The gender of a foetus can also be determined using NIPT. Non Invasive Prenatal Testing is used to identify the most not unusual chromosome anomalies like Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and the Patau Syndrome (Trisomy thirteen).
Browse full Report @ https://www.marketdataforecast.com/market-reports/non-Invasive-prenatal-testing-market-2818/
The growth of the Global Non-Invasive Prenatal Testing Market is in particular driven by way of elements inclusive of the advent of newer and more advanced NIPT merchandise, the feasibility and developing choice for non-invasive techniques over invasive ones, growing danger of chromosomal abnormalities in toddlers with growing maternal age and favourable reimbursement for NIPT. Key agencies are playing a major role I increasing the boundaries of cf-DNA research with tries being at figuring out approximately 20,000 genetic characteristic via a single sample in a unmarried response. The possibilities of fake positives coupled with the lower clinical validity of specially the microdeletion section are the various main restraints of the market.
Get Free Sample Report @ https://www.marketdataforecast.com/market-reports/non-Invasive-prenatal-testing-market-2818/request-sample
The Global Non-Invasive Prenatal Testing Market is segmented based on Instruments, Method of Screening, Application, End User and geography. Based on Instruments, the marketplace is divided into Ultrasound, NGS, PCR and Microarray. Based on Method, the Non-Invasive Prenatal Testing Market is segmented into FCMB and cf-DNA. Further, by means of Application, the market is branched into Trisomy, Microdeletion, Genetics, and Rh issue. Based on the End User, it is classified into Hospital and Diagnostic Labs.
Avail Discount @ https://www.marketdataforecast.com/market-reports/non-Invasive-prenatal-testing-market-2818/request-discount
The market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America leads the market in 2016, with the U.S. Accounting for a first-rate share. North America’s lead is justified by the presence of high-quit era, it being a evolved market combined with the developing occurrence of genetic abnormalities. Europe comes in 2nd in phrases of marketplace proportion because of the growing consciousness and status quo of MIPT approaches. However, Asia-Pacific is estimated to grow at the highest CAGR at some stage in the forecast duration majorly due to the presence of exponentially extra population numbers.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/non-Invasive-prenatal-testing-market-2818/
The Non-Invasive Prenatal Testing market is very plenty fragmented in nature with the presence of worldwide and neighborhood gamers. The important gamers inside the market implement numerous techniques such as product launches, and approvals, product innovation, R&D funding for advancement in Non-Invasive Prenatal Testing, with acquisitions, and mergers as their developmental techniques to undergo the aggressive putting of the market. The key gamers in the Non-Invasive Prenatal Testing market are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China)
About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
The gender of a foetus can also be determined using NIPT. Non Invasive Prenatal Testing is used to identify the most not unusual chromosome anomalies like Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), and the Patau Syndrome (Trisomy thirteen).
Browse full Report @ https://www.marketdataforecast.com/market-reports/non-Invasive-prenatal-testing-market-2818/
The growth of the Global Non-Invasive Prenatal Testing Market is in particular driven by way of elements inclusive of the advent of newer and more advanced NIPT merchandise, the feasibility and developing choice for non-invasive techniques over invasive ones, growing danger of chromosomal abnormalities in toddlers with growing maternal age and favourable reimbursement for NIPT. Key agencies are playing a major role I increasing the boundaries of cf-DNA research with tries being at figuring out approximately 20,000 genetic characteristic via a single sample in a unmarried response. The possibilities of fake positives coupled with the lower clinical validity of specially the microdeletion section are the various main restraints of the market.
Get Free Sample Report @ https://www.marketdataforecast.com/market-reports/non-Invasive-prenatal-testing-market-2818/request-sample
The Global Non-Invasive Prenatal Testing Market is segmented based on Instruments, Method of Screening, Application, End User and geography. Based on Instruments, the marketplace is divided into Ultrasound, NGS, PCR and Microarray. Based on Method, the Non-Invasive Prenatal Testing Market is segmented into FCMB and cf-DNA. Further, by means of Application, the market is branched into Trisomy, Microdeletion, Genetics, and Rh issue. Based on the End User, it is classified into Hospital and Diagnostic Labs.
Avail Discount @ https://www.marketdataforecast.com/market-reports/non-Invasive-prenatal-testing-market-2818/request-discount
The market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America leads the market in 2016, with the U.S. Accounting for a first-rate share. North America’s lead is justified by the presence of high-quit era, it being a evolved market combined with the developing occurrence of genetic abnormalities. Europe comes in 2nd in phrases of marketplace proportion because of the growing consciousness and status quo of MIPT approaches. However, Asia-Pacific is estimated to grow at the highest CAGR at some stage in the forecast duration majorly due to the presence of exponentially extra population numbers.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/non-Invasive-prenatal-testing-market-2818/
The Non-Invasive Prenatal Testing market is very plenty fragmented in nature with the presence of worldwide and neighborhood gamers. The important gamers inside the market implement numerous techniques such as product launches, and approvals, product innovation, R&D funding for advancement in Non-Invasive Prenatal Testing, with acquisitions, and mergers as their developmental techniques to undergo the aggressive putting of the market. The key gamers in the Non-Invasive Prenatal Testing market are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China)
About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results